Drug intelligence / Profile preview

Clobeta

Development stage
Unknown
Lead developer
Saffron Pharmaceuticals
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Topical
01

Overview

Clobeta is a topical corticosteroid medication developed and marketed by Saffron Pharma, available in both cream and ointment formulations. The active ingredient is clobetasol propionate, which is classified as a super-high potency (Group I) corticosteroid. It works by binding to cytoplasmic glucocorticoid receptors and subsequently moving into the cell nucleus, where it binds to glucocorticoid response elements (GREs) on the DNA. This action induces the synthesis of inhibitory proteins called lipocortins, which in turn inhibit phospholipase A2. By inhibiting this enzyme, Clobeta reduces the release of arachidonic acid, thereby decreasing the production of inflammatory mediators such as prostaglandins and leukotrienes. It is primarily used to treat severe inflammatory skin conditions, including psoriasis, eczema (including contact dermatitis), lichen planus, and skin manifestations of lupus.

Brand names
Clobeta
Other names
Clobeta CreamClobeta Ointment
02

Targets

GR (Glucocorticoid receptor)CYP3A5 (Cytochrome P450 family 3 subfamily A member 5)

Beyond the preview

Go deeper on Clobeta.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clobeta.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call